Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Monday's Exclusive Story 3 "Forever Stocks" to Hold When the Market Won't Sit StillBy Chris Markoch. Publication Date: 1/19/2026. 
Summary - Chevron provides long-term income potential through disciplined buybacks, a growing dividend, and exposure to global energy markets.
- Colgate-Palmolive delivers consistency with a diversified brand portfolio and more than six decades of annual dividend increases.
- Merck combines near-term cash flow from Keytruda with a late-stage oncology pipeline aimed at sustaining future growth.
With ongoing market volatility, it's a good time for investors to consider stocks they can hold for the long haul. These compounders don't have to dominate your portfolio, but they're valuable for investors who prefer to step away from their screens. Owning "forever stocks" is about more than chasing the next hot trade. It means building a portfolio around companies with durable competitive advantages, resilient cash flows, and shareholder-friendly capital allocation. Those are businesses that can weather economic cycles, adapt to industry shifts, and continue rewarding investors through dividends and long-term appreciation. Amazon has quietly poured $144 million into a secretive AI chip company, and committed to buying a staggering $650 million of their product. Why? Because this obscure startup holds the key to unleashing the full potential of Nvidia's revolutionary Blackwell chip. Discover the company at the heart of the AI arms race. Large-cap leaders with global footprints often fit this profile. They benefit from scale, strong brands, and balance sheets that let them invest through downturns while returning capital to shareholders. While even the best companies can experience periods of underperformance, history shows patience is often rewarded when the underlying business remains strong. Chevron: Energy Income With Long-Term Staying Power Chevron Corp. (NYSE: CVX) is a large-cap integrated oil company with operations in the Permian Basin, several deep-water drilling projects, and investments in renewables. CVX's stock price is sensitive to oil-price fluctuations. That sensitivity is a major reason the stock has returned just 5.1% over the past three years. Despite high production levels, crude remains in the high $50s to low $60s per barrel, which has pressured earnings. Still, this piece focuses on owning forever stocks. Over the last 10 years, CVX has delivered a total return of more than 200%. The company has a consistent record of share buybacks and a safe, growing dividend. The dividend yield at the time of writing is 4.12%. More important may be the annualized dividend payment of $6.84 per share and Chevron's status as a dividend aristocrat with 38 consecutive years of dividend increases. Colgate-Palmolive: A Dividend King Built for Consistency Colgate-Palmolive Co. (NYSE: CL) is a leading name among consumer staples stocks. With a deep portfolio of global brands, Colgate benefits from predictable, long-term consumer demand—an idea that echoes Peter Lynch's advice to "own what you know." Investors who bought the stock in recent years have needed patience. This "forever" stock has produced a total return of about 15% over the past five years, which includes the company's dividend, currently yielding 2.47%. Over longer time horizons, CL has been a reliable compounder of wealth thanks to its status as a dividend king, having increased its payout for 63 consecutive years. Trading at roughly 22 times earnings, the stock looks reasonably valued relative to its own history and compared with the broader market. Merck: Pipeline-Driven Growth Beyond Keytruda Merck & Co. (NYSE: MRK) delivered a volatile 2025, falling to around $72 at its low—about 45% below its June 2024 peak. Like the others on this list, MRK has been a difficult hold recently, returning just over 10% across the past three years. Nearly half of Merck's revenue comes from its blockbuster cancer drug Keytruda. Keytruda doesn't face a patent cliff until 2028, but institutional investors are already focused on how Merck will replace that revenue. The challenge mirrors the one AbbVie faced with Humira, and AbbVie managed to offset much of that revenue loss. Merck's potential solution is its development pipeline. The company is seeking approval for additional Keytruda indications and has 16 oncology drugs in late-stage trials. If one or two of those candidates are approved in the coming years, they could meaningfully offset any future revenue shortfall. These three names illustrate the trade-offs of owning forever stocks: near-term volatility and periodic underperformance can coexist with strong long-term returns, reliable dividends, and durable businesses that compound value over time.
| 
